# The Effects of SGC on Glucose Control in Critically Ill Patients With Sepsis

> **NCT02980588** · NA · UNKNOWN · sponsor: **Southeast University, China** · enrollment: 60 (estimated)

## Conditions studied

- Sepsis
- Hyperglycemia
- Critical Illness

## Interventions

- **DEVICE:** SGC directed glycemic control

## Key facts

- **NCT ID:** NCT02980588
- **Lead sponsor:** Southeast University, China
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-12
- **Primary completion:** 2017-05
- **Final completion:** 2017-09
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2016-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02980588

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02980588, "The Effects of SGC on Glucose Control in Critically Ill Patients With Sepsis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02980588. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*